Viewing Study NCT06562192


Ignite Creation Date: 2025-12-24 @ 3:51 PM
Ignite Modification Date: 2025-12-25 @ 1:57 PM
Study NCT ID: NCT06562192
Status: RECRUITING
Last Update Posted: 2025-12-16
First Post: 2024-08-16
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module